Health
Sinopharm vaccine for COVID-19 elicits immunity to South Africa variant, but with minor effect – Explica
BEIJING, Feb 3 (.) – Two COVID-19 vaccines from Chinese companies, including Sinopharm, elicited immunity against a highly communicable variant of the coronavirus…
BEIJING, Feb 3 (.) – Two COVID-19 vaccines from Chinese companies, including Sinopharm, elicited immunity against a highly communicable variant of the coronavirus first found in South Africa, but its effect appeared to be weaker, a study showed laboratory with small samples.
Variants of the virus have raised concerns that they may weaken the effects of vaccines and treatments developed before their emergence.
Twelve serum samples taken from recipients of two vaccines developed by a Sinopharm subsidiary…
-
Business19 hours ago1 ASX dividend stock down 43% I’d buy right now
-
Noosa News18 hours agoBanana farmers still salvaging fruit four weeks after ex-Tropical Cyclone Alfred
-
Business23 hours agoBattle of the ASX ETFs: Why has VGS outperformed VTS this year?
-
Business22 hours ago5 things to watch on the ASX 200 on Monday 7 April 2025